-+ 0.00%
-+ 0.00%
-+ 0.00%

SKYE BIOSCIENCE INC - CRC APPROVES ENROLLMENT IN COHORT 2 (600 MG IV) AFTER FAVORABLE SAFETY REVIEW OF COHORT 1

Reuters·05/20/2026 11:00:01

Please log in to view news